Silver Book Fact

Anti-VEGF Visual Improvement

Fact image

Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.

Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye: Clinical trial results from MARINA and ANCHOR. Ophthalmol. 2010; 117(4): 747-56. http://www.aaojournal.org/article/S0161-6420(09)00981-6/abstract

Reference

Title
Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye: Clinical trial results from MARINA and ANCHOR
Publication
Ophthalmol
Publication Date
2010
Volume & Issue
Volume 117, Issue 4
Pages
747-56
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Participants in a diabetes self-management education program for Medicaid recipients, consisting of a 60 minute initial individual assessment of needs, followed by 12 hours of group education on nutrition and…  
  • Remote Interpretation of Retinal Imaging for DR
    Use of remote interpretation of retinal imaging in diabetics sent via tele-ophthalmology, improved the frequency of screening from 32% to 71% in only 12 months.  
  • Projected change in 3-year diabetes-related costs and 10-year disease event rates among Medicaid recipients participating in a diabetes self-management education program consisting of a 60 minute initial individual assessment of…  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Laser treatments save up to $1.6 billion per year through prevention and treatment of blindness in diabetics.